| Mr Jeffrey Scott Copeland, MSN ARNP | |
|
500 Limit St, Leavenworth, KS 66048-4435 | |
| (913) 682-5118 | |
| (913) 682-4664 |
| Full Name | Mr Jeffrey Scott Copeland |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 26 Years |
| Location | 500 Limit St, Leavenworth, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811905078 | NPI | - | NPPES |
| 10418200B | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 74651 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Guidance Center, Inc | 6507859063 | 13 |
News Archive
A National autoimmune disease multi-city conference tour arrives in Charleston, SC on Saturday, November 2, 2013. The conference "What Every American Needs to Know About Autoimmune Disease," is one of a series of free patient forums hosted by the American Autoimmune Related Diseases Association.
Currently, the best way to predict whether a breast cancer is likely to recur is to determine whether tumor cells have invaded the lymph nodes near the breast.
Scientists in the UK say they have detected four new genes believed to be involved in the development of breast cancer.
GE Healthcare, a pioneer in digital mammography, today announced the introduction of an innovative technology to aid in breast cancer diagnosis. GE Healthcare's new SenoBright Contrast Enhanced Spectral Mammography technology reduces ambiguity in mammography results, enabling physicians to detect and diagnose cancer with more confidence - even in the densest part of the breast tissue more rapidly and accurately.
› Verified 4 days ago
| Entity Name | The Guidance Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841262839 PECOS PAC ID: 6507859063 Enrollment ID: O20040408000528 |
News Archive
A National autoimmune disease multi-city conference tour arrives in Charleston, SC on Saturday, November 2, 2013. The conference "What Every American Needs to Know About Autoimmune Disease," is one of a series of free patient forums hosted by the American Autoimmune Related Diseases Association.
Currently, the best way to predict whether a breast cancer is likely to recur is to determine whether tumor cells have invaded the lymph nodes near the breast.
Scientists in the UK say they have detected four new genes believed to be involved in the development of breast cancer.
GE Healthcare, a pioneer in digital mammography, today announced the introduction of an innovative technology to aid in breast cancer diagnosis. GE Healthcare's new SenoBright Contrast Enhanced Spectral Mammography technology reduces ambiguity in mammography results, enabling physicians to detect and diagnose cancer with more confidence - even in the densest part of the breast tissue more rapidly and accurately.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jeffrey Scott Copeland, MSN ARNP 500 Limit St, Leavenworth, KS 66048-4435 Ph: (913) 682-5118 | Mr Jeffrey Scott Copeland, MSN ARNP 500 Limit St, Leavenworth, KS 66048-4435 Ph: (913) 682-5118 |
News Archive
A National autoimmune disease multi-city conference tour arrives in Charleston, SC on Saturday, November 2, 2013. The conference "What Every American Needs to Know About Autoimmune Disease," is one of a series of free patient forums hosted by the American Autoimmune Related Diseases Association.
Currently, the best way to predict whether a breast cancer is likely to recur is to determine whether tumor cells have invaded the lymph nodes near the breast.
Scientists in the UK say they have detected four new genes believed to be involved in the development of breast cancer.
GE Healthcare, a pioneer in digital mammography, today announced the introduction of an innovative technology to aid in breast cancer diagnosis. GE Healthcare's new SenoBright Contrast Enhanced Spectral Mammography technology reduces ambiguity in mammography results, enabling physicians to detect and diagnose cancer with more confidence - even in the densest part of the breast tissue more rapidly and accurately.
› Verified 4 days ago
Denette Vonada-smith, NP-C Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 |